Literature DB >> 27383824

The association of CYP1A1 genetic polymorphisms and additional gene-gene interaction with ischemic stroke in the eastern Han of China.

Meng Zhang1,2, Jian-Ming Wu2, Qiu-Sheng Zhang2, Da-Wei Yan2, Li-Jie Ren3, Wei-Ping Li4.   

Abstract

The aim of this study was to investigate the association between CYP1A1 gene polymorphism and ischaemic stroke (IS) risk, and the impact of gene-gene interaction on IS risk based on a Chinese Han case-control study. A total of 1162 subjects (612 men and 550 women), with a mean age of 63.1 ± 12.5 years old, were selected, including 580 IS patients and 582 normal controls. Logistic regression was performed to investigate association between single-nucleotide polymorphisms (SNP) and IS risk, and generalized multifactor dimensionality reduction (GMDR) was used to analyze the gene-gene interaction. Logistic regression analysis showed that the frequency for rs4646903 minor alleles was lower in cases than that in normal controls, and C allele of rs4646903 was 20.7 % in ischemic stroke cases and 27.1 % in controls subjects (p < 0.001). Logistic analysis showed the significant association between genotypes of variants in rs4646903 and decreased ischemic stroke risk. GMDR analysis indicated that there was a significant two-locus model (p = 0.0107) involving rs4646903 and rs1048943, indicating a potential gene-gene interaction between rs4646903 and rs1048943. Overall, the two- locus models had a cross-validation consistency of 9 of 10, and had the testing accuracy of 60.72 %. Subjects with TC or CC of rs4646903 and AG or GG of rs1048943 genotype have lowest ischemic stroke risk, compared to subjects with TT of rs4646903 and AA of rs1048943 genotype, and OR (95 % CI) was 0.63 (0.42-0.89). rs4646903 minor alleles and interaction between rs4646903 and rs1048943 were associated with decreased IS risk.

Entities:  

Keywords:  CYP1A1; Interaction; Ischaemic stroke; Polymorphism

Mesh:

Substances:

Year:  2016        PMID: 27383824     DOI: 10.1007/s10072-016-2652-4

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  27 in total

Review 1.  The global stroke initiative.

Authors:  Ruth Bonita; Shanthi Mendis; Thomas Truelsen; Julien Bogousslavsky; James Toole; Frank Yatsu
Journal:  Lancet Neurol       Date:  2004-07       Impact factor: 44.182

Review 2.  Genetics of stroke.

Authors:  Jin-min Guo; Ai-jun Liu; Ding-feng Su
Journal:  Acta Pharmacol Sin       Date:  2010-08-23       Impact factor: 6.150

3.  Endothelial nitric oxide synthase gene interactions and the risk of ischaemic stroke.

Authors:  Z Szolnoki; V Havasi; J Bene; K Komlósi; D Szöke; F Somogyvári; A Kondacs; M Szabó; L Fodor; A Bodor; I Gáti; I Wittman; B Melegh
Journal:  Acta Neurol Scand       Date:  2005-01       Impact factor: 3.209

4.  Interaction between CYP1A1 T3801C and AHR G1661A polymorphisms according to smoking status on blood pressure in the Stanislas cohort.

Authors:  Nicolas Gambier; Jean-Brice Marteau; Anne-Marie Batt; Bérangère Marie; Annick Thompson; Gérard Siest; Dorothee Foernzler; Sophie Visvikis-Siest
Journal:  J Hypertens       Date:  2006-11       Impact factor: 4.844

5.  Functional significance of different human CYP1A1 genotypes.

Authors:  F Crofts; E Taioli; J Trachman; G N Cosma; D Currie; P Toniolo; S J Garte
Journal:  Carcinogenesis       Date:  1994-12       Impact factor: 4.944

6.  Association of CYP1A1 Gene Polymorphism with Ischemic Stroke in South Indian Population.

Authors:  Shehnaz Sultana; Venkata Karunakar Kolla; Vidyullatha Peddireddy; Yasovanthi Jeedigunta; Pranay K Penagaluru; Sindhu Joshi; Usha Rani Penagaluru; Pardhananda Reddy Penagaluru
Journal:  Transl Stroke Res       Date:  2011-01-20       Impact factor: 6.829

Review 7.  The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature.

Authors:  D W Nebert; D R Nelson; M J Coon; R W Estabrook; R Feyereisen; Y Fujii-Kuriyama; F J Gonzalez; F P Guengerich; I C Gunsalus; E F Johnson
Journal:  DNA Cell Biol       Date:  1991 Jan-Feb       Impact factor: 3.311

8.  The association between CYP1A1 genetic polymorphisms and coronary artery disease in the Uygur and Han of China.

Authors:  Jin-Guo Zou; Yi-Tong Ma; Xiang Xie; Yi-Ning Yang; Shuo Pan; Dilare Adi; Fen Liu; Bang-Dang Chen
Journal:  Lipids Health Dis       Date:  2014-09-05       Impact factor: 3.876

9.  Cytochrome P450 1A1 (CYP1A1) T6325C polymorphism might modulate essential hypertension-associated stroke risk.

Authors:  V Lança; P Alcântara; J Braz-Nogueira; M P Bicho
Journal:  Rev Port Cardiol       Date:  2004-03       Impact factor: 1.374

10.  CYP1A1 and GSTM1/T1 genetic variation in predicting risk for cerebral infarction.

Authors:  Kyung-Suk Moon; Hye-Jung Lee; Seung-Heon Hong; Hyung-Min Kim; Jae-Young Um
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 2.866

View more
  3 in total

1.  Advances in clinical neurology through the journal "Neurological Sciences" (2015-2016).

Authors:  Ilaria Di Donato; Antonio Federico
Journal:  Neurol Sci       Date:  2017-01       Impact factor: 3.307

Review 2.  Aryl hydrocarbon receptor pathway: Role, regulation and intervention in atherosclerosis therapy (Review).

Authors:  Kaixi Zhu; Qingqi Meng; Zhi Zhang; Tao Yi; Yuan He; Jing Zheng; Wei Lei
Journal:  Mol Med Rep       Date:  2019-10-16       Impact factor: 2.952

3.  The influence of CYP1A1 and CYP1A2 polymorphisms on stroke risk in the Chinese population.

Authors:  Yan Mao; Lin Yang; Qian Chen; Guoqing Li; Yao Sun; Jiamin Wu; Zichao Xiong; Yuanwei Liu; Haiyue Li; Jianfeng Liu; Yong Zhang
Journal:  Lipids Health Dis       Date:  2020-10-12       Impact factor: 3.876

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.